These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 9611723)
1. [Extrapyramidalism associated with the use of cisapride]. Mariscal E; Sagalés M; Pedrol E; Pedrol E; Montull S Med Clin (Barc); 1998 Apr; 110(12):477-8. PubMed ID: 9611723 [No Abstract] [Full Text] [Related]
2. [Severe proarrhythmias in cisapride therapy. Simple precautionary measures reduce the risk]. Darpö B Lakartidningen; 1997 Nov; 94(47):4317-20. PubMed ID: 9424525 [No Abstract] [Full Text] [Related]
9. Aggravation of parkinsonian tremor by cisapride. Sempere AP; Duarte J; Cabezas C; Clavería LE; Coria F Clin Neuropharmacol; 1995 Feb; 18(1):76-8. PubMed ID: 8665538 [TBL] [Abstract][Full Text] [Related]
10. Polypharmacy in elders. Lilley LL; Guanci R Am J Nurs; 1996 Nov; 96(11):12-4. PubMed ID: 8918348 [No Abstract] [Full Text] [Related]
11. FDA, Janssen bolster cardiac risk warnings for cisapride. Miller JL Am J Health Syst Pharm; 2000 Mar; 57(5):414. PubMed ID: 10711516 [No Abstract] [Full Text] [Related]
12. Cisapride-induced long QT interval: what is the role of ranitidine? Gunasekaran TS; DuBrow I J Pediatr; 1997 Apr; 130(4):679-80. PubMed ID: 9108876 [No Abstract] [Full Text] [Related]
13. Cardiac arrhythmias associated with coadministration of azole compounds and cisapride. Chan-Tompkins NH; Babinchak TJ Clin Infect Dis; 1997 Jun; 24(6):1285. PubMed ID: 9195113 [No Abstract] [Full Text] [Related]
15. Cisapride in reducing postoperative gastrocaecal transit time after cardiac surgery in children. Jenkins IR Intensive Care Med; 1997 Apr; 23(4):482-3. PubMed ID: 9142596 [No Abstract] [Full Text] [Related]
16. The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada. Walker AM; Szneke P; Weatherby LB; Dicker LW; Lanza LL; Loughlin JE; Yee CL; Dreyer NA Am J Med; 1999 Oct; 107(4):356-62. PubMed ID: 10527038 [TBL] [Abstract][Full Text] [Related]
17. A comparison of two cohort studies evaluating the safety of cisapride: Prescription-Event Monitoring and a large phase IV study. Wager E; Tooley PJ; Pearce GL; Wilton LV; Mann RD Eur J Clin Pharmacol; 1997; 52(2):87-94. PubMed ID: 9174676 [TBL] [Abstract][Full Text] [Related]
18. Cisapride-induced dysrhythmia in a pediatric patient receiving extracorporeal life support. Pettignano R; Chambliss CR; Darsey E; Heard M; Clark R Crit Care Med; 1996 Jul; 24(7):1268-71. PubMed ID: 8674348 [No Abstract] [Full Text] [Related]
19. Urinary disorders associated with cisapride. Adverse Drug Reactions Advisory Committee. Boyd IW; Rohan AP Med J Aust; 1994 May; 160(9):579-80. PubMed ID: 8164559 [No Abstract] [Full Text] [Related]
20. Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future. Layton D; Key C; Shakir SA Pharmacoepidemiol Drug Saf; 2003; 12(1):31-40. PubMed ID: 12616845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]